InflaRx N.V. (IFRX) stock
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.18+0.01 (+0.85%)
Close on Nov 16, 2026Market cap $85.31MP/E –Yield –
InflaRx total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
InflaRx's total debt was €2.15M at Jun 30, 2022. For fiscal 2021 it was €0.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | €0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2022 | Jun 30, 2022 | €2.15M | – |
| Q4 FY2021 | Dec 31, 2021 | €0 | – |
See a number that looks wrong?